Nordhealth AS
OSE:NORDH.OL
23.4 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue
| 36.825 | 31.049 | 20.3 | 12.684 |
| Cost of Revenue
| 5.171 | 4.78 | 3.562 | 1.751 |
| Gross Profit
| 31.654 | 26.269 | 16.738 | 10.933 |
| Gross Profit Ratio
| 0.86 | 0.846 | 0.825 | 0.862 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1.448 | 1.89 | 3.527 | 0.891 |
| Selling & Marketing Expenses
| 1.652 | 1.818 | 0.408 | 0.135 |
| SG&A
| 3.1 | 3.708 | 3.935 | 1.026 |
| Other Expenses
| 0 | 37.24 | 17.26 | 7.933 |
| Operating Expenses
| 43.041 | 40.948 | 21.195 | 8.959 |
| Operating Income
| -11.387 | -14.679 | -4.457 | 1.975 |
| Operating Income Ratio
| -0.309 | -0.473 | -0.22 | 0.156 |
| Total Other Income Expenses Net
| 0.581 | 0.551 | -0.189 | 0.026 |
| Income Before Tax
| -10.806 | -14.128 | -4.646 | 2.001 |
| Income Before Tax Ratio
| -0.293 | -0.455 | -0.229 | 0.158 |
| Income Tax Expense
| 0.326 | 0.136 | 0.085 | 0.073 |
| Net Income
| -11.132 | -14.264 | -4.731 | 1.928 |
| Net Income Ratio
| -0.302 | -0.459 | -0.233 | 0.152 |
| EPS
| -0.14 | -0.18 | -0.059 | 0.043 |
| EPS Diluted
| -0.14 | -0.18 | -0.059 | 0.024 |
| EBITDA
| -0.659 | -5.408 | -0.369 | 3.554 |
| EBITDA Ratio
| -0.018 | -0.174 | -0.018 | 0.28 |